BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16251483)

  • 1. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy.
    Chanda S; Dasgupta UB; Guhamazumder D; Gupta M; Chaudhuri U; Lahiri S; Das S; Ghosh N; Chatterjee D
    Toxicol Sci; 2006 Feb; 89(2):431-7. PubMed ID: 16251483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic exposure induces genomic hypermethylation.
    Majumdar S; Chanda S; Ganguli B; Mazumder DN; Lahiri S; Dasgupta UB
    Environ Toxicol; 2010 Jun; 25(3):315-8. PubMed ID: 19437452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between the methylation and mutation of p53 gene and endemic arsenism caused by coal-burning].
    Zhang AH; Pan XL; Xia YJ; Xiao Q; Huang XX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):393-8. PubMed ID: 21756780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China.
    Zhang AH; Bin HH; Pan XL; Xi XG
    J Toxicol Environ Health A; 2007 Jun; 70(11):970-5. PubMed ID: 17479413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide induces aberrant hypermethylation of Hic-1 in mouse embryonic fibroblasts lacking p53 gene.
    Tatemichi M; Hata H; Tazawa H; Nakadate T
    Anticancer Res; 2008; 28(4B):2101-8. PubMed ID: 18751382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects.
    Banerjee N; Paul S; Sau TJ; Das JK; Bandyopadhyay A; Banerjee S; Giri AK
    Toxicol Sci; 2013 Oct; 135(2):300-8. PubMed ID: 23872714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.
    Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S
    Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
    Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
    Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
    Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of inorganic arsenicals on the methylation of p16 gene CpG islands and the expression of p16 gene in BEP2D cells].
    Lu G; Cai Q; Zhang W
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1238-41. PubMed ID: 11825526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
    Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
    Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.